In fact, Hajjar et al. reported that the expression of S100A10 in glioma cells is not affected by stable depletion of annexin A2, probably owing to binding partners of S100A10 other than annexin A2, in her response to letters to her article [59]. The gene discussed is ANXA2; the disease is central nervous system cancer.